finally , we discuss the long-term results ( at 10 years of follow-up ) of a front-line protocol using ifosfamide/methotrexate/etoposide ( imvp-16 ) as consolidation or intensification for cyclophosphamide , doxorubicin , vincristine , prednisone ( chop ) responders .
C0025677
methotrexate
C0063445
imvp-16